• New Chromabond® Drug Ii

Chromatography

New Chromabond® Drug Ii

Macherey Nagel GmbH introduces a specific cartridge for solid phase extraction for enrichment of THC (tetrahydrocannabinol) and THC-derivates from blood or urine. The determination of tetrahydrocannabinol and its metabolites is an important procedure in analysis of drugs of abuse and is offered as standard routine method by many laboratories. After enrichment of the analytes respectively pre-cleaning of the sample by SPE subsequent identification by GC/MS is proceeded.

CHROMABOND® Drug II contains a bifunctional adsorbent material, consisting from a strong anion exchanger (SAX, quaternary amine) and C8 modified silica. Two primary retention mechanisms facilitate the use of very strong interferant eluting solvents resulting in very pure extracts especially from heavily matrix loaded samples like urine, plasma, serum or whole blood.

Already available from Macaherey Nagel is CHROMABOND® Drug a SPE-cartridge for enrichment of acidic, neutral and basic drugs. By introducing CHROMABOND® Drug II the scope of SPE products for drug analysis is widened by the important group of THCs.

Digital Edition

ILM 50.3 April 2025

May 2025

Chromatography Articles - Optimising two-step purification: Key considerations for sample pump setups Mass Spectrometry & Spectroscopy Articles - Detecting pharmaceuticals and their transf...

View all digital editions

Events

Future Labs Live Basel 2025

May 27 2025 Basel, Switzerland

ASMS Conference

Jun 01 2025 Baltimore, MD, USA

Chemspec Europe 2025

Jun 04 2025 Koeln, Germany

Lab & Test Asia

Jun 11 2025 Bangkok, Thailand

HPLC 2025

Jun 15 2025 Bruges, Belgium

View all events